| 今开：0.0 | 昨收：0.0 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.85147E7 |
Pharmathene(PIP)2019-08-15 01:05
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-13 AccNo: 0001564590-19-031811 Size: 395 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文
Pharmathene(PIP)2019-08-17 09:55
$Pharmathene(PIP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-14 AccNo: 0001193125-19-221188 Size: 52 KB 网页链接查看全文
Pharmathene(PIP)2019-08-15 01:05
$Pharmathene(PIP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001564590-19-031795 Size: 5 MB 网页链接查看全文
Pharmathene(PIP)2019-08-11 03:00
$Pharmathene(PIP)$ PRE 14A - Other preliminary proxy statements Filed: 2019-08-09 AccNo: 0001193125-19-218069 Size: 921 KB 网页链接查看全文
Pharmathene(PIP)2019-10-02 04:50
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001193125-19-259847 Size: 38 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...查看全文
Pharmathene(PIP)2019-08-23 14:35
$Pharmathene(PIP)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-22 AccNo: 0001193125-19-226618 Size: 964 KB 网页链接查看全文
Pharmathene(PIP)2019-08-22 15:10
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-21 AccNo: 0001193125-19-225595 Size: 34 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接查看全文
Pharmathene(PIP)2019-08-21 03:40
$Pharmathene(PIP)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2019-08-19 AccNo: 0001193125-19-224357 Size: 965 KB 网页链接查看全文
Pharmathene(PIP)2019-07-16 02:45
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-15 AccNo: 0001193125-19-193586 Size: 39 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements a...查看全文
Pharmathene(PIP)2019-06-22 11:25
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-06-21 AccNo: 0001193125-19-178904 Size: 20 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接查看全文
Pharmathene(PIP)2019-06-13 14:15
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-06-12 AccNo: 0001193125-19-171212 Size: 96 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial St...查看全文
Pharmathene(PIP)2019-06-08 15:30
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-06-07 AccNo: 0001193125-19-168149 Size: 16 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接查看全文
Pharmathene(PIP)2019-05-15 12:35
$Pharmathene(PIP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-14 AccNo: 0001564590-19-019139 Size: 4 MB 网页链接查看全文
Pharmathene(PIP)2019-05-15 12:35
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-05-14 AccNo: 0001564590-19-019146 Size: 310 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文
Pharmathene(PIP)2019-04-15 23:50
$Pharmathene(PIP)$ EFFECT - Notice of Effectiveness Filed: 2019-04-12 AccNo: 9999999995-19-000701 Size: 1 KB 网页链接查看全文
Pharmathene(PIP)2019-04-05 10:55
$Pharmathene(PIP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-04-04 AccNo: 0001193125-19-097986 Size: 125 KB 网页链接查看全文
Pharmathene(PIP)2019-04-05 10:55
$Pharmathene(PIP)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-04-04 AccNo: 0001193125-19-097996 Size: 573 KB 网页链接查看全文
Pharmathene(PIP)2019-04-02 11:05
$Pharmathene(PIP)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-01 AccNo: 0001564590-19-010429 Size: 13 MB 网页链接查看全文
Pharmathene(PIP)2019-04-02 11:05
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-04-01 AccNo: 0001564590-19-010435 Size: 336 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001193125-19-259847 Size: 38 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...
$Pharmathene(PIP)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-22 AccNo: 0001193125-19-226618 Size: 964 KB 网页链接
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-21 AccNo: 0001193125-19-225595 Size: 34 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Pharmathene(PIP)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2019-08-19 AccNo: 0001193125-19-224357 Size: 965 KB 网页链接
$Pharmathene(PIP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-14 AccNo: 0001193125-19-221188 Size: 52 KB 网页链接
$Pharmathene(PIP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001564590-19-031795 Size: 5 MB 网页链接
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-13 AccNo: 0001564590-19-031811 Size: 395 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Pharmathene(PIP)$ PRE 14A - Other preliminary proxy statements Filed: 2019-08-09 AccNo: 0001193125-19-218069 Size: 921 KB 网页链接
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-15 AccNo: 0001193125-19-193586 Size: 39 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements a...
$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-09 AccNo: 0001193125-19-190926 Size: 7 MBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibi...